Abstract
The dengue virus affects millions of people every year worldwide, causing large epidemic outbreaks that disrupt people’s lives and severely strain healthcare systems. In the absence of a reliable vaccine against it or an effective treatment to manage the illness in humans, most efforts to combat dengue infections have focused on preventing its vectors, mainly the Aedes aegypti mosquito, from flourishing across the world. These mosquito-control strategies need reliable disease activity surveillance systems to be deployed. Despite significant efforts to estimate dengue incidence using a variety of data sources and methods, little work has been done to understand the relative contribution of the different data sources to improved prediction. Additionally, most work has focused on prediction systems at the national level, rather than at finer spatial resolutions. We develop a methodological framework to assess and compare dengue incidence estimates at the city level and evaluate the performance of a collection of models on 20 different cities in Brazil. The data sources we use towards this end are weekly incidence counts from prior years (seasonal autoregressive terms), weekly-aggregated weather variables, and real-time internet search data. We find that a random forest-based model effectively leverages these multiple data sources and provides robust predictions, while retaining interpretability. For real-time predictions that assume long delays (6-8 weeks) in the availability of epidemiological data, we find that real-time internet search data are the strongest predictors of Dengue incidence, whereas for predictions that assume very short delays (1-2 weeks), short-term and seasonal autocorrelation are dominant as predictors. Despite the difficulties inherent to city-level prediction, our framework achieves meaningful and actionable estimates across cities with different characteristics.
Author Summary As the incidence of infectious diseases like dengue continues to increase throughout world, tracking their spread in real time poses a significant challenge to local and national health authorities. Accurate incidence data are often impossible to obtain as outbreaks emerge and unfold, and a range of nowcasting tools have been developed to estimate disease trends using different mathematical methodologies to fill the temporal data gap. Over the past several years, researchers have investigated how to best incorporate internet search data into predictive models, since these can be obtained in real-time. Still, most such models have been regression-based, and have tended to underperform in cases when epidemiological data are only available after long reporting delays. Moreover, in tropical countries, these models have previously been tested and applied primarily at the national level. Here, we develop a machine learning model based on a random forest approach and apply it in 20 cities in Brazil. We find that our methodology produces meaningful and actionable disease estimates at the city level, and that it is more robust to delays in the availability of epidemiological data than regression-based models.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
MS was partially supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01GM130668. GK, CB, and MS thank the Harvard Data Science Initiative for their support in the early stages of this project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB was necessary since all the data used for the study are publicly available, aggregated geographically, and anonymized.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All the data used for this study are either publicly available as reported in the manuscript, or available upon request.
